ANDREONI SIMONA
- U08, Piano: 2, Stanza: 2056
Pubblicazioni
Sala, G., Cuffaro, L., Pozzi, F., Andreoni, S., Bazzini, C., Conti, E., et al. (2025). Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network). FRONTIERS IN AGING NEUROSCIENCE, 17 [10.3389/fnagi.2025.1581892]. Dettaglio
Pozzi, F., Conti, E., Remoli, G., Dell'Orto, N., Andreoni, S., Da Re, F., et al. (2025). Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study. JPAD, 12(2) [10.1016/j.tjpad.2024.100027]. Dettaglio
Conti, E., Grana, D., Angiulli, F., Karantzoulis, A., Villa, C., Combi, R., et al. (2023). TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease. JOURNAL OF ALZHEIMER'S DISEASE, 95(2), 549-559 [10.3233/JAD-230239]. Dettaglio
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I., et al. (2023). Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) [Altro] [10.1038/s41467-023-36192-x]. Dettaglio
Turri, M., Conti, E., Pavanello, C., Gastoldi, F., Palumbo, M., Bernini, F., et al. (2023). Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease. ALZHEIMER'S RESEARCH & THERAPY, 15(1 (December 2023)) [10.1186/s13195-023-01241-6]. Dettaglio